EUVIMEDEUVIMED entdecken
Crossref

Comparative systemic inflammatory marker patterns across Hashimoto’s thyroiditis, Graves’ disease, and non-autoimmune goiter

Selçuk Akan, Yavuz Selim Sılay

FAMILY PRACTICE AND PALLIATIVE CARE · 21.07.2026 · 11 (2) · 130-137

DOI: 10.22391/fppc.1896375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FAMILY PRACTICE AND PALLIATIVE CARE, online erschienen am 21.07.2026. Verfasst von Selçuk Akan und 1 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Gefördert von: Ankara Bilkent City Hospital.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Autoimmune thyroid diseases (AITDs), including Hashimoto’s thyroiditis (HT) and Graves’ disease (GD), are characterized by immune-mediated thyroid dysfunction. However, whether systemic inflammatory burden differs among thyroid disease phenotypes remains unclear.

Methods

In this cross-sectional study, 100 adult patients (HT n=60, GD n=11, goiter n=29) were evaluated. Serum C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), neutrophil-to-lymphocyte ratio (NLR), and procalcitonin levels were compared among groups using the Kruskal–Wallis test with Bonferroni-adjusted post-hoc analyses. General linear models adjusted for age, sex, and disease duration were applied. Associations between inflammatory markers and thyroid parameters were assessed using Spearman correlation analysis.

Results

CRP (p=0.638), ESR (p=0.135), and NLR (p=0.466) did not differ significantly among the three thyroid phenotypes. Although statistically significant differences in procalcitonin levels were observed between groups (p=0.031), lower measurable values were observed in the Graves’ disease group, and this difference remained significant after adjustment for confounders (adjusted p=0.041). Correlation analyses demonstrated generally weak associations between inflammatory markers and thyroid autoantibodies, with only a modest correlation between procalcitonin and TRAb reaching statistical significance (r=0.22, p=0.048).

Conclusions

Routine systemic inflammatory markers do not meaningfully distinguish autoimmune from non-autoimmune thyroid disease phenotypes. Although procalcitonin demonstrated a phenotype-related difference, its clinical relevance remains uncertain. These findings support the concept that autoimmune thyroid diseases predominantly reflect localized rather than systemic inflammatory activation.

Förderung

  • Ankara Bilkent City Hospital

Zitieren

APA

Akan, S., & Sılay, Y. S. (2026). Comparative systemic inflammatory marker patterns across Hashimoto’s thyroiditis, Graves’ disease, and non-autoimmune goiter. FAMILY PRACTICE AND PALLIATIVE CARE, 11(2), 130-137. https://doi.org/10.22391/fppc.1896375

Vancouver

Akan S, Sılay YS. Comparative systemic inflammatory marker patterns across Hashimoto’s thyroiditis, Graves’ disease, and non-autoimmune goiter. FAMILY PRACTICE AND PALLIATIVE CARE. 2026;11(2):130-137. doi:10.22391/fppc.1896375

BibTeX
@article{Akan2026,
  author = {Akan, Selçuk and Sılay, Yavuz Selim},
  title = {Comparative systemic inflammatory marker patterns across Hashimoto’s thyroiditis, Graves’ disease, and non-autoimmune goiter},
  journal = {FAMILY PRACTICE AND PALLIATIVE CARE},
  year = {2026},
  volume = {11},
  number = {2},
  pages = {130--137},
  doi = {10.22391/fppc.1896375}
}
Kostenlos starten →